Historic Veterans’ Prostate Cancer Bill Passes Unopposed in the House September 23, 2020 STATEMENT FOR IMMEDIATE RELEASEMedia Contact: Ilana Ostrinilana@zerocancer.org202-657-2249 WASHINGTON, D.C. – The House unanimously passed H.R. 6092, the “Veteran’s Prostate Cancer Treatment and Research Act,” designed to establish a national clinical pathway for prostate cancer. This standardized system of care would enhance treatment and increase access to clinical trials via a registry for the most commonly diagnosed cancer in the Veterans Health Administration.“Our service members have dedicated their lives to the American people and they deserve to receive the same high quality care any one of us would expect when faced with a diagnosis of prostate cancer,” said Alison Manson, ZERO’s Vice President of Advocacy and Government Relations. “ZERO applauds the House of Representatives for its efforts to ensure that the nearly half a million veterans facing prostate cancer are no longer subjected to the risks of an unorganized health system.” Congressman Neal Dunn, M.D. (FL-02), a former urologist, sponsored this effort. No timetable has been set for when the Senate may vote on the measure, but it’s expected to move quickly through the Senate.Veterans face prostate cancer at rates that double those of civilians. For more information on ZERO’s work with veterans, visit zerocancer.org/veterans. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org About Prostate Cancer Advocacy Press Release Research Spreading Awareness Treatment Options More for you
STATEMENT FOR IMMEDIATE RELEASEMedia Contact: Ilana Ostrinilana@zerocancer.org202-657-2249 WASHINGTON, D.C. – The House unanimously passed H.R. 6092, the “Veteran’s Prostate Cancer Treatment and Research Act,” designed to establish a national clinical pathway for prostate cancer. This standardized system of care would enhance treatment and increase access to clinical trials via a registry for the most commonly diagnosed cancer in the Veterans Health Administration.“Our service members have dedicated their lives to the American people and they deserve to receive the same high quality care any one of us would expect when faced with a diagnosis of prostate cancer,” said Alison Manson, ZERO’s Vice President of Advocacy and Government Relations. “ZERO applauds the House of Representatives for its efforts to ensure that the nearly half a million veterans facing prostate cancer are no longer subjected to the risks of an unorganized health system.” Congressman Neal Dunn, M.D. (FL-02), a former urologist, sponsored this effort. No timetable has been set for when the Senate may vote on the measure, but it’s expected to move quickly through the Senate.Veterans face prostate cancer at rates that double those of civilians. For more information on ZERO’s work with veterans, visit zerocancer.org/veterans.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
